BR9406923A - Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos - Google Patents

Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos

Info

Publication number
BR9406923A
BR9406923A BR9406923A BR9406923A BR9406923A BR 9406923 A BR9406923 A BR 9406923A BR 9406923 A BR9406923 A BR 9406923A BR 9406923 A BR9406923 A BR 9406923A BR 9406923 A BR9406923 A BR 9406923A
Authority
BR
Brazil
Prior art keywords
compounds
heteroazolyl
heterocyclyl
chronic
acute
Prior art date
Application number
BR9406923A
Other languages
English (en)
Inventor
Bernard Robin Boar
Alan John Cross
Duncan Alastair Gray
Alfred Richard Green
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9406923A publication Critical patent/BR9406923A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9406923A 1993-07-06 1994-07-05 Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos BR9406923A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302332A SE9302332D0 (sv) 1993-07-06 1993-07-06 New compounds
PCT/SE1994/000663 WO1995001979A1 (en) 1993-07-06 1994-07-05 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents

Publications (1)

Publication Number Publication Date
BR9406923A true BR9406923A (pt) 1996-07-30

Family

ID=20390539

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406923A BR9406923A (pt) 1993-07-06 1994-07-05 Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos

Country Status (24)

Country Link
US (2) US5731335A (pt)
EP (1) EP0707584A1 (pt)
JP (1) JPH08512312A (pt)
CN (1) CN1126994A (pt)
AU (1) AU691506B2 (pt)
BR (1) BR9406923A (pt)
CA (1) CA2164856A1 (pt)
CZ (1) CZ5396A3 (pt)
EE (1) EE03193B1 (pt)
EG (1) EG20569A (pt)
FI (1) FI960076A (pt)
HU (1) HUT75097A (pt)
IL (1) IL110157A (pt)
IS (1) IS4182A (pt)
MX (1) MX9405110A (pt)
NO (1) NO305955B1 (pt)
NZ (1) NZ268689A (pt)
PL (1) PL176471B1 (pt)
RU (1) RU2124011C1 (pt)
SE (1) SE9302332D0 (pt)
SG (1) SG64891A1 (pt)
SK (1) SK159895A3 (pt)
WO (1) WO1995001979A1 (pt)
ZA (1) ZA944569B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
DE19645313A1 (de) 1996-11-04 1998-05-07 Basf Ag Substituierte 3-Benzylpyrazole
CA2311125C (en) 1997-11-19 2011-01-18 Takeda Chemical Industries, Ltd. Apoptosis inhibitor
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
AU4589701A (en) 2000-03-24 2001-10-08 Cocensys Inc Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
BRPI0506749A (pt) 2004-01-12 2007-05-22 Applied Research Systems derivados de tiazol e uso dos mesmos
EP1794167A4 (en) * 2004-09-10 2009-10-21 Syngenta Ltd SUBSTITUTED ISOXAZOLE AS FUNGICIDES
US7888376B2 (en) * 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101711242B (zh) * 2007-05-23 2013-09-25 阿勒根公司 作为肾上腺素能受体激动剂的((二环杂芳基)咪唑基)甲基杂芳基化合物
WO2009123164A1 (ja) * 2008-04-02 2009-10-08 塩野義製薬株式会社 血管内皮リパーゼ阻害活性を有するヘテロ環誘導体
WO2012010567A1 (en) * 2010-07-19 2012-01-26 Syngenta Participations Ag Isoxazole, isothiazole, furane and thiophene compounds as microbicides
EP2447261A1 (en) * 2010-10-29 2012-05-02 Basf Se Pyrrole, furane and thiophene derivatives and their use as fungicides
JP2014525442A (ja) * 2011-08-30 2014-09-29 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 金属酵素阻害化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な1,2,4−オキサジアゾ−ル誘導体
JPH01249760A (ja) * 1988-03-29 1989-10-05 Yamaha Corp ホトクロミック化合物
US5068237A (en) * 1990-05-21 1991-11-26 Warner-Lambert Company Substituted furans and derivatives thereof acting at muscarinic receptors
AU3171493A (en) * 1991-12-31 1993-07-28 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity

Also Published As

Publication number Publication date
FI960076A0 (fi) 1996-01-08
NO305955B1 (no) 1999-08-23
ZA944569B (en) 1995-02-15
WO1995001979A1 (en) 1995-01-19
AU7197794A (en) 1995-02-06
HU9503744D0 (en) 1996-02-28
FI960076A (fi) 1996-01-08
IL110157A0 (en) 1994-10-07
SK159895A3 (en) 1996-09-04
IS4182A (is) 1995-01-07
AU691506B2 (en) 1998-05-21
SG64891A1 (en) 1999-05-25
US5731335A (en) 1998-03-24
NO960028L (no) 1996-02-27
PL176471B1 (pl) 1999-06-30
MX9405110A (es) 1995-01-31
HUT75097A (en) 1997-04-28
RU2124011C1 (ru) 1998-12-27
CZ5396A3 (en) 1996-06-12
NZ268689A (en) 1997-11-24
CA2164856A1 (en) 1995-01-19
NO960028D0 (no) 1996-01-04
EE03193B1 (et) 1999-06-15
JPH08512312A (ja) 1996-12-24
CN1126994A (zh) 1996-07-17
PL312417A1 (en) 1996-04-15
SE9302332D0 (sv) 1993-07-06
IL110157A (en) 2000-01-31
US5607956A (en) 1997-03-04
EG20569A (en) 1999-08-30
EP0707584A1 (en) 1996-04-24

Similar Documents

Publication Publication Date Title
BR9302737A (pt) Derivados de tiazolivinilfenila,processo para a preparacao de um composto,medicamento,uso e processos para tratar ou prevenir asma bronquica
BR9609780A (pt) Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto
BR9406128A (pt) Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
BR9609467A (pt) Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária
BR9607089A (pt) Compostos de pirimidina condensada biciclica composição farmacéutica utilização e produtos que contém os mesmos e processo para a preparação desses compostos
BR9406566A (pt) Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica
BR8706496A (pt) Processo para preparacao de compostos e utilizacao
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
PT90994A (pt) Processo para a preparacao de um sistema para a preparacao de composicoes para aplicacao topica
BR9612204A (pt) Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor
PT98369A (pt) Processo para a preparacao de azois substituidos e de composicoes farmaceuticas que os contem
BR9611377A (pt) Inibidor de trombina de ligação não lenta processo para preparar o mesmo composição farmacêutica e uso do inibidor de trombina
BR9406923A (pt) Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos
BR9506473A (pt) Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas
BR9502471A (pt) Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica
BR9106117A (pt) Antraquinona substituida,composicao farmaceutica para inibir quinase c de proteina,processo para tal inibicao e uso de um composto
BR9005793A (pt) Composicao de fluoreto estanoso aquoso estabilizada e processo para preparacao da mesma
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
BR9600339A (pt) Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos
BR9607264A (pt) Composto derivado do isotiuréia composição farmacêutica uso de tal composto e processo para a preparação dos mesmos
BR8803768A (pt) Composicao odorante,processo para producao de compostos e uso dos ditos compostos
BR9406924A (pt) Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal